{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T03:53:52Z","timestamp":1700193232658},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:00:00Z","timestamp":1448582400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Neuraminidase inhibitor (NI) dispensing has emerged as a possible automated data source for influenza surveillance. We aimed to evaluate its timeliness, correlation, and predictive accuracy in relation to influenza activity in Quebec, Canada, 2010\u20132013. Our secondary objective was to use the same metrics to compare NI dispensing to visits for influenza-like illness (ILI) in emergency departments (EDs). Provincial weekly counts of positive influenza laboratory tests were used as a reference measure for the level of influenza circulation. We applied ARIMA models to account for serial correlation. We computed cross-correlations to measure the strengths of association and lead-lag relationships between NI dispensing, ILI ED visits, and our reference indicator. Finally, using an ARIMA model, we evaluated the ability of NI dispensing and ILI ED visits to predict laboratory-confirmed influenza. NI dispensing was significantly correlated (<jats:italic>R<\/jats:italic>= 0\u00b768) with influenza activity with no lag. The maximal correlation of ILI ED visits was not as strong (<jats:italic>R<\/jats:italic>= 0\u00b750). Both NI dispensing and ILI ED visits were significant predictors of laboratory-confirmed influenza in a multivariable model; predictive potential was greatest when NI counts were lagged to precede laboratory surveillance by 2 weeks. We conclude that NI dispensing data provides timely and valuable information for influenza surveillance.<\/jats:p>","DOI":"10.1017\/s095026881500299x","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T10:28:24Z","timestamp":1448620104000},"page":"1592-1600","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza"],"prefix":"10.1017","volume":"144","author":[{"given":"J.","family":"PAPENBURG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"CHARLAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"DE SERRES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"BUCKERIDGE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,11,27]]},"reference":[{"key":"S095026881500299X_ref1","doi-asserted-by":"publisher","DOI":"10.1086\/507558"},{"key":"S095026881500299X_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp195"},{"key":"S095026881500299X_ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03968.x"},{"key":"S095026881500299X_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2010.10.001"},{"key":"S095026881500299X_ref36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3201\/eid1803.111351","article-title":"Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands","volume":"18","author":"Fiejt\u00e9","year":"2012","journal-title":"Emerging Infectious Diseases"},{"key":"S095026881500299X_ref28","first-page":"401","article-title":"Value of pharmacy-based influenza surveillance \u2013 Ontario, Canada, 2009","volume":"62","author":"Aramini","year":"2013","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S095026881500299X_ref15","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec. Surveillance for influenza and other viral respiratory infections (http:\/\/www.inspq.qc.ca\/influenza\/surveillance-de-l-influenza). Accessed 2 October 2015."},{"key":"S095026881500299X_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu422"},{"key":"S095026881500299X_ref29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7883\/yoken.JJID.2009.233","article-title":"Seasonal influenza surveillance using prescription data for anti-influenza medications","volume":"62","author":"Yoshida","year":"2009","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"S095026881500299X_ref26","unstructured":"Centers for Disease Control and Prevention. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection (http:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/molecular-assays.htm). Accessed 2 October 2015."},{"key":"S095026881500299X_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12226"},{"key":"S095026881500299X_ref27","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3883"},{"key":"S095026881500299X_ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092153"},{"key":"S095026881500299X_ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/10.1.87"},{"key":"S095026881500299X_ref21","volume-title":"Time Series Analysis: Forecasting and Control","year":"2008"},{"key":"S095026881500299X_ref18","doi-asserted-by":"publisher","DOI":"10.1177\/096228029600500102"},{"key":"S095026881500299X_ref22","volume-title":"Time Series: Theory and Methods","year":"1991"},{"key":"S095026881500299X_ref12","doi-asserted-by":"publisher","DOI":"10.3201\/eid1010.030789"},{"key":"S095026881500299X_ref14","doi-asserted-by":"publisher","DOI":"10.1177\/875647939000600106"},{"key":"S095026881500299X_ref20","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M2178"},{"key":"S095026881500299X_ref16","doi-asserted-by":"publisher","DOI":"10.1086\/598513"},{"key":"S095026881500299X_ref39","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31826cc1df"},{"key":"S095026881500299X_ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008945"},{"key":"S095026881500299X_ref37","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr037"},{"key":"S095026881500299X_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi257"},{"key":"S095026881500299X_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00390.x"},{"key":"S095026881500299X_ref38","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.05.19112-en","article-title":"Use of oseltamivir in 12 european countries between 2002 and 2007 \u2013 lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses","volume":"14","author":"Kramarz","year":"2009","journal-title":"Eurosurveillance"},{"key":"S095026881500299X_ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/879141"},{"key":"S095026881500299X_ref13","doi-asserted-by":"publisher","DOI":"10.1002\/9780470131886"},{"key":"S095026881500299X_ref32","doi-asserted-by":"publisher","DOI":"10.3201\/eid1408.080074"},{"key":"S095026881500299X_ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0910060"},{"key":"S095026881500299X_ref4","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M2328"},{"key":"S095026881500299X_ref25","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1881"},{"key":"S095026881500299X_ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058290"},{"key":"S095026881500299X_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06528-X"},{"key":"S095026881500299X_ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094130"},{"key":"S095026881500299X_ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3837"},{"key":"S095026881500299X_ref2","unstructured":"World Health Organisation. WHO global epidemiological surveillance standards for influenza (http:\/\/www.who.int\/influenza\/resources\/documents\/influenza_surveillance_manual\/en\/index.html). Accessed 2 October 2015."},{"key":"S095026881500299X_ref33","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.09.19806-en","article-title":"Evaluation of syndromic surveillance in the Netherlands: its added value and recommendations for implementation","volume":"16","author":"van den Wijngaard","year":"2011","journal-title":"Eurosurveillance"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026881500299X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:17:22Z","timestamp":1692145042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026881500299X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,27]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S095026881500299X"],"URL":"https:\/\/doi.org\/10.1017\/s095026881500299x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,27]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2015\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}